Axim Biotechnologies, Versea Ophthalmics Partner to Commercialize Eye Disease Tests
Versea will have the exclusive commercial right to Axim's point-of-care readers and three diagnostic tests for eye disease.
NIMA Partners, EmpowerDx Collaborate on Celiac Gene Test
The assay from EmpowerDx uses self-collected oral swabs to identify genetic risk for the autoimmune disease, and the companies offer results within 10 business days.
Becton Dickinson to Offer Accelerate Diagnostics AST Systems Under Collaboration
Accelerate also separately announced that its net sales grew 39 percent in the second quarter due to increases in both capital and recurring revenues.
Maxim Biomedical, Thomas Scientific Ink Distribution Deal for OTC COVID-19 Antigen Test
The lateral flow assay received Emergency Use Authorization from the US Food and Drug Administration earlier this month for at-home use.
Maverick Health to Offer Visby Medical Rapid Coronavirus Test
Visby's single-use, fully integrated assay is designed to detect SARS-CoV-2 nucleic acid in samples collected either by a healthcare provider or self-collected.